US Patent Issued to Centrexion Therapeutics on July 1 for "(cyano-dimethyl-methyl)-isoxazoles and -[1,3,4thiadiazoles" (German Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,344,601, issued on July 1, was assigned to Centrexion Therapeutics Corp. (Boston).

"(cyano-dimethyl-methyl)-isoxazoles and -[1,3,4thiadiazoles" was invented by Doris Riether (Biberach an der Riss, Germany), Florian Paul Christian Binder (Maselheim, Germany), Henri Doods (Warthausen, Germany), Stephan George Mueller (Warthausen, Germany), Janet Rachel Nicholson (Oberhoefen, Germany) and Achim Sauer (Ravensburg-Torkenweiler, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to novel (Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles and their use as CB2 cannabinoid receptor agonists, pharmaceutical compositions containi...